title: Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients.
authors.forename: J
authors.initials: J
authors.lastname: Pérez-Calvo
authors.forename: O
authors.initials: O
authors.lastname: Fernández-Hidalgo
authors.forename: M L
authors.initials: ML
authors.lastname: Subirá
authors.forename: S
authors.initials: S
authors.lastname: Martín-Algarra
authors.forename: E
authors.initials: E
authors.lastname: Salgado
authors.forename: A
authors.initials: A
authors.lastname: Brugarolas
mesh_terms: D018952:Antigens, CD34; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D000069585:Filgrastim; D005472:Fluorouracil / Q000008:administration & dosage; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods* / Q000592:standards; D006801:Humans; D007937:Leukapheresis / Q000379:methods / Q000592:standards; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives*; D011994:Recombinant Proteins; D043823:Taxoids
chemical_list: D018952:Antigens, CD34; D011994:Recombinant Proteins; D043823:Taxoids; D016179:Granulocyte Colony-Stimulating Factor; D000077143:Docetaxel; D004317:Doxorubicin; D017239:Paclitaxel; D000069585:Filgrastim; D005472:Fluorouracil